Altre lingue Immuron Limited

Azioni

Mercato chiuso - Australian S.E. Altri mercati azionari 08:10:44 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,105 ^AUD	0,00%		+5,00%	+36,36%

10/04	Le vendite globali di Immuron salgono del 51% nel trimestre di marzo; le azioni aumentano del 18%	MT
07/03	Aggiornamento settoriale: i titoli del settore sanitario guadagnano nel tardo pomeriggio	MT

Immuron to host Live Virtual Event	15/04
Immuron Travelan® sales continued strong growth	10/04
Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	10/04
Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	10/04
Sector Update: Health Care Stocks Gain Late Afternoon	07/03
Sector Update: Health Care	07/03
Top Midday Gainers	07/03
Top Premarket Gainers	07/03
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	07/03
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US	07/03
Immuron Limited Announces Positive Results Support Travelan Progress to Phase 3 Clinical Trials in the US	07/03
Immuron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Immuron Presentation Australian Biologics Festival 2024	21/02
Immuron Presentation Australian Biologics Festival 2024	21/02
Immuron achieves record Travelan® sales	13/02
Immuron achieves record Travelan® sales	13/02
Immuron Limited Reports Unaudited Net Sales Results for the Year to Date Ended January 2024	13/02
Immuron's Travelan Immune Supplement Registers AU$2.7 Million Sales in YTD January	13/02
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	08/02
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	08/02

Non ci sono risultati per questa ricerca